0001193125-13-307929.txt : 20130730 0001193125-13-307929.hdr.sgml : 20130730 20130729192158 ACCESSION NUMBER: 0001193125-13-307929 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130531 FILED AS OF DATE: 20130730 DATE AS OF CHANGE: 20130729 EFFECTIVENESS DATE: 20130730 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPPENHEIMER CAPITAL APPRECIATION FUND CENTRAL INDEX KEY: 0000319767 IRS NUMBER: 133054122 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-03105 FILM NUMBER: 13993795 BUSINESS ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 BUSINESS PHONE: 303-768-3200 MAIL ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 FORMER COMPANY: FORMER CONFORMED NAME: OPPENHEIMER TARGET FUND DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: OPPENHEIMER TARGET FUND INC DATE OF NAME CHANGE: 19870616 0000319767 S000006959 OPPENHEIMER CAPITAL APPRECIATION FUND C000018983 A C000018984 B C000018985 C C000018986 N C000018987 Y C000109448 I N-Q 1 d549337dnq.htm OPPENHEIMER CAPITAL APPRECIATION FUND Oppenheimer Capital Appreciation Fund

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM N-Q

 

 

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED

MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number 811-3105

 

 

Oppenheimer Capital Appreciation Fund

(Exact name of registrant as specified in charter)

 

 

6803 South Tucson Way, Centennial, Colorado 80112-3924

(Address of principal executive offices) (Zip code)

 

 

Arthur S. Gabinet

OFI Global Asset Management, Inc.

Two World Financial Center, New York, New York 10281-1008

(Name and address of agent for service)

 

 

Registrant’s telephone number, including area code: (303) 768-3200

Date of fiscal year end: August 31

Date of reporting period: 5/31/2013

 

 

 


Item 1. Schedule of Investments.


STATEMENT OF INVESTMENTS May 31, 2013 / Unaudited

 

     Shares      Value  

Common Stocks—98.3%

     

Consumer Discretionary—15.6%

  

  

Hotels, Restaurants & Leisure—3.0%

  

  

McDonald’s Corp.

     799,780       $ 77,234,755   

Panera Bread Co., Cl. A1

     168,480         32,319,518   

Yum! Brands, Inc.

     524,170         35,512,518   
     

 

 

 
        145,066,791   
     

 

 

 

Internet & Catalog Retail—1.7%

  

  

Amazon.com, Inc.1

     297,130         79,936,884   
     

 

 

 

Media—2.9%

     

News Corp., Cl. B

     964,800         31,105,152   

Walt Disney Co. (The)

     1,749,034         110,329,065   
     

 

 

 
        141,434,217   
     

 

 

 

Specialty Retail—4.8%

     

Home Depot, Inc. (The)

     331,540         26,078,937   

O’Reilly Automotive, Inc.1

     787,743         85,793,090   

Tiffany & Co.

     614,269         47,777,843   

TJX Cos., Inc. (The)

     1,475,602         74,680,217   
     

 

 

 
        234,330,087   
     

 

 

 

Textiles, Apparel & Luxury Goods—3.2%

  

Nike, Inc., Cl. B

     1,253,946         77,318,310   

Ralph Lauren Corp., Cl. A

     275,477         48,233,268   

VF Corp.

     167,860         30,862,740   
     

 

 

 
        156,414,318   
     

 

 

 

Consumer Staples—11.8%

     

Beverages—4.1%

     

Brown-Forman Corp., Cl. B

     737,773         50,773,538   

Coca-Cola Co. (The)

     1,820,286         72,793,237   

SABMiller plc

     1,507,490         75,826,109   
     

 

 

 
        199,392,884   
     

 

 

 

Food & Staples Retailing—1.8%

  

  

Costco Wholesale Corp.

     797,355         87,445,923   
     

 

 

 

Food Products—2.5%

     

Mead Johnson Nutrition Co.

     633,840         51,385,409   

Nestle SA

     1,030,633         68,008,247   
     

 

 

 
        119,393,656   
     

 

 

 

Household Products—1.2%

     

Colgate-Palmolive Co.

     987,810         57,134,930   
     

 

 

 

Personal Products—1.3%

     

Estee Lauder Cos., Inc. (The), Cl. A

     898,050         60,869,829   
     

 

 

 

Tobacco—0.9%

     

Philip Morris International, Inc.

     480,480         43,680,437   
     Shares      Value  

Energy—7.0%

     

Energy Equipment & Services—3.7%

  

  

Cameron International Corp.1

     934,370       $ 56,875,102   

FMC Technologies, Inc.1

     777,770         43,290,678   

Oceaneering International, Inc.

     469,530         34,031,535   

Schlumberger Ltd.

     612,546         44,734,234   
     

 

 

 
        178,931,549   
     

 

 

 

Oil, Gas & Consumable Fuels—3.3%

  

  

Cabot Oil & Gas Corp.

     476,060         33,495,581   

Chevron Corp.

     375,400         46,080,350   

Noble Energy, Inc.

     672,420         38,765,013   

Phillips 66

     587,652         39,119,994   
     

 

 

 
        157,460,938   
     

 

 

 

Financials—4.5%

     

Capital Markets—3.3%

     

Amerprise Financial, Inc.

     58,620         4,778,702   

Charles Schwab Corp. (The)

     2,009,530         39,909,266   

Goldman Sachs Group, Inc. (The)

     363,530         58,920,943   

Northern Trust Corp.

     971,460         56,490,399   
     

 

 

 
        160,099,310   
     

 

 

 

Consumer Finance—1.2%

     

American Express Co.

     771,463         58,407,464   
     

 

 

 

Health Care—15.6%

     

Biotechnology—5.4%

     

Biogen Idec, Inc.1

     292,220         69,399,328   

Celgene Corp.1

     319,070         39,453,006   

Gilead Sciences, Inc.1

     1,018,500         55,487,880   

Medivation, Inc.1

     513,820         24,951,099   

Vertex Pharmaceuticals, Inc.1

     890,300         71,499,993   
     

 

 

 
        260,791,306   
     

 

 

 

Health Care Equipment & Supplies—1.1%

  

Baxter International, Inc.

     759,512         53,416,479   
     

 

 

 

Health Care Technology—1.5%

  

  

Cerner Corp.1

     717,530         70,518,848   
     

 

 

 

Life Sciences Tools & Services—0.8%

  

  

Mettler-Toledo International, Inc.1

     177,056         38,644,243   
     

 

 

 

Pharmaceuticals—6.8%

     

Allergan, Inc.

     542,140         53,937,509   

Bristol-Myers Squibb Co.

     1,593,393         73,312,012   
 

 

1    OPPENHEIMER CAPITAL APPRECIATION FUND


STATEMENT OF INVESTMENTS Unaudited / (Continued)

 

     Shares      Value  

Pharmaceuticals (Continued)

     

Novo Nordisk AS, Cl. B

     554,684       $ 89,049,217   

Perrigo Co.

     468,030         54,249,357   

Roche Holding AG

     244,200         60,424,923   
     

 

 

 
     330,973,018   
     

 

 

 

Industrials—13.4%

     

Aerospace & Defense—4.0%

  

  

Honeywell International, Inc.

     659,510         51,745,154   

Precision Castparts Corp.

     209,400         44,794,848   

TransDigm Group, Inc.

     264,320         38,617,152   

United Technologies Corp.

     639,824         60,719,298   
     

 

 

 
     195,876,452   
     

 

 

 

Building Products—0.5%

     

Fortune Brands Home & Security, Inc.

     525,280         22,208,838   
     

 

 

 

Electrical Equipment—2.5%

  

  

AMETEK, Inc.

     587,000         25,329,050   

Eaton Corp. plc

     693,810         45,833,089   

Rockwell Automation, Inc.

     220,590         19,416,332   

Roper Industries, Inc.

     226,180         28,096,079   
     

 

 

 
     118,674,550   
     

 

 

 

Machinery—1.3%

     

Cummins, Inc.

     373,230         44,649,505   

Ingersoll-Rand plc

     342,240         19,689,067   
     

 

 

 
     64,338,572   
     

 

 

 

Road & Rail—3.3%

     

J.B. Hunt Transport Services, Inc.

     724,900         53,396,134   

Kansas City Southern

     398,740         44,140,518   

Union Pacific Corp.

     417,178         64,504,062   
     

 

 

 
        162,040,714   
     

 

 

 

Trading Companies & Distributors—1.8%

  

United Rentals, Inc.1

     835,810         47,507,440   

W.W. Grainger, Inc.

     154,400         39,748,736   
     

 

 

 
        87,256,176   
     

 

 

 

Information Technology—24.9%

  

  

Communications Equipment—4.0%

  

  

Cisco Systems, Inc.

     405,350         9,760,828   

QUALCOMM, Inc.

     2,869,140         182,133,007   
     

 

 

 
        191,893,835   
     

 

 

 

Computers & Peripherals—5.9%

  

  

Apple, Inc.

     611,774         275,102,532   

EMC Corp.1

     393,500         9,743,060   
     

 

 

 
        284,845,592   
     

 

 

 

Internet Software & Services—5.6%

  

eBay, Inc.1

     1,680,045         90,890,434   
    Shares     Value  

Internet Software & Services (Continued)

  

Google, Inc., Cl. A1

    208,017      $ 181,060,077   
   

 

 

 
      271,950,511   
   

 

 

 

IT Services—4.6%

   

Cognizant Technology Solutions Corp., Cl. A1

    818,620        52,923,783   

Fiserv, Inc.1

    277,270        24,166,853   

Teradata Corp.1

    1,131,325        63,071,369   

Visa, Inc., Cl. A

    467,249        83,235,737   
   

 

 

 
      223,397,742   
   

 

 

 

Semiconductors & Semiconductor Equipment—2.9%

  

Avago Technologies Ltd.

    1,146,730        43,243,188   

Broadcom Corp., Cl. A

    1,812,667        65,092,872   

Xilinx, Inc.

    743,460        30,221,649   
   

 

 

 
      138,557,709   
   

 

 

 

Software—1.9%

   

Intuit, Inc.

    90,646        5,297,352   

Salesforce.com, Inc.1

    1,995,670        84,476,711   
   

 

 

 
      89,774,063   
   

 

 

 

Materials—5.5%

   

Chemicals—4.5%

   

Ecolab, Inc.

    825,933        69,766,561   

Monsanto Co.

    851,510        85,695,966   

PPG Industries, Inc.

    399,820        61,416,350   
   

 

 

 
      216,878,877   
   

 

 

 

Containers & Packaging—1.0%

  

 

Crown Holdings, Inc.1

    1,134,670        48,053,275   
   

 

 

 

Total Common Stocks
(Cost $3,084,637,818)

      4,750,090,017   
   

 

 

 

Investment Company—1.9%

  

 

Oppenheimer Institutional Money Market Fund, Cl. E, 0.12%2,3

   

(Cost $93,508,518)

    93,508,518        93,508,518   
   

 

 

 

Total Investments, at Value

   

(Cost $3,178,146,336)

    100.2     4,843,598,535   
   

 

 

 

Liabilities in Excess of Other Assets

    (0.2     (9,361,528
   

 

 

 

Net Assets

    100.0   $ 4,834,237,007   
   

 

 

 
 

 

2    OPPENHEIMER CAPITAL APPRECIATION FUND


STATEMENT OF INVESTMENTS Unaudited / (Continued)

 

Footnotes to Statement of Investments

 

1. Non-income producing security.
2. Is or was an affiliate, as defined in the Investment Company Act of 1940, at or during the period ended May 31, 2013, by virtue of the Fund owning at least 5% of the voting securities of the issuer or as a result of the Fund and the issuer having the same investment adviser. Transactions during the period in which the issuer was an affiliate are as follows:

 

     Shares
August 31, 2012
     Gross
Additions
     Gross
Reductions
     Shares
May  31,

2013
 

Oppenheimer Institutional Money Market Fund, Cl. E

     47,634,088         611,714,302         565,839,872         93,508,518   

 

     Value      Income  

Oppenheimer Institutional Money Market Fund, Cl. E

   $ 93,508,518       $ 66,875  

 

3. Rate shown is the 7-day yield as of May 31, 2013.

 

3    OPPENHEIMER CAPITAL APPRECIATION FUND


NOTES TO STATEMENT OF INVESTMENTS Unaudited

Investment in Oppenheimer Institutional Money Market Fund. The Fund is permitted to invest daily available cash balances in an affiliated money market fund. The Fund may invest the available cash in Class E shares of Oppenheimer Institutional Money Market Fund (“IMMF”) to seek current income while preserving liquidity. IMMF is a registered open-end management investment company, regulated as a money market fund under the Investment Company Act of 1940, as amended. The Manager is the investment adviser of IMMF, and the Sub-Adviser provides investment and related advisory services to IMMF. When applicable, the Fund’s investment in IMMF is included in the Statement of Investments. Shares of IMMF are valued at their net asset value per share. As a shareholder, the Fund is subject to its proportional share of IMMF’s Class E expenses, including its management fee. The Manager will waive fees and/or reimburse Fund expenses in an amount equal to the indirect management fees incurred through the Fund’s investment in IMMF.

Foreign Currency Translation. The Fund’s accounting records are maintained in U.S. dollars. The values of securities denominated in foreign currencies and amounts related to the purchase and sale of foreign securities and foreign investment income are translated into U.S. dollars as of the close of the Exchange, normally 4:00 P.M. Eastern time, on each day the Exchange is open for trading. Foreign exchange rates may be valued primarily using a reliable bank, dealer or service authorized by the Board of Trustees.

Securities Valuation

The Fund calculates the net asset value of its shares as of the close of the New York Stock Exchange (the “Exchange”), normally 4:00 P.M. Eastern time, on each day the Exchange is open for trading.

The Fund’s Board has adopted procedures for the valuation of the Fund’s securities and has delegated the day-to-day responsibility for valuation determinations under those procedures to the Manager. The Manager has established a Valuation Committee which is responsible for determining a “fair valuation” for any security for which market quotations are not “readily available.” The Valuation Committee’s fair valuation determinations are subject to review, approval and ratification by the Fund’s Board at its next regularly scheduled meeting covering the calendar quarter in which the fair valuation was determined.

Valuation Methods and Inputs

Securities are valued using unadjusted quoted market prices, when available, as supplied primarily by third party pricing services or dealers.

The following methodologies are used to determine the market value or the fair value of the types of securities described below:

Securities traded on a registered U.S. securities exchange (including exchange-traded derivatives other than futures and futures options) are valued based on the last sale price of the security reported on the principal exchange on which it is traded, prior to the time when the Fund’s assets are valued. In the absence of a sale, the security is valued at the last sale price on the prior trading day, if it is within the spread of the current day’s closing “bid” and “asked” prices, and if not, at the current day’s closing bid price. A security of a foreign issuer traded on a foreign exchange but not listed on a registered U.S. securities exchange is valued

 

4    OPPENHEIMER CAPITAL APPRECIATION FUND


NOTES TO STATEMENT OF INVESTMENTS Unaudited / (Continued)

Securities Valuation (Continued)

 

based on the last sale price on the principal exchange on which the security is traded, as identified by the third party pricing service used by the Manager, prior to the time when the Fund’s assets are valued. If the last sale price is unavailable, the security is valued at the most recent official closing price on the principal exchange on which it is traded. If the last sales price or official closing price for a foreign security is not available, the security is valued at the mean between the bid and asked price per the exchange or, if not available from the exchange, obtained from two dealers. If bid and asked prices are not available from either the exchange or two dealers, the security is valued by using one of the following methodologies (listed in order of priority); (1) using a bid from the exchange, (2) the mean between the bid and asked price as provided by a single dealer, or (3) a bid from a single dealer.

Shares of a registered investment company that are not traded on an exchange are valued at that investment company’s net asset value per share.

Corporate and government debt securities (of U.S. or foreign issuers) and municipal debt securities, event-linked bonds, loans, mortgage-backed securities, collateralized mortgage obligations, and asset-backed securities are valued at the mean between the “bid” and “asked” prices utilizing evaluated prices obtained from third party pricing services or broker-dealers who may use matrix pricing methods to determine the evaluated prices.

Short-term money market type debt securities with a remaining maturity of sixty days or less are valued at cost adjusted by the amortization of discount or premium to maturity (amortized cost), which approximates market value. Short-term debt securities with a remaining maturity in excess of sixty days are valued at the mean between the “bid” and “asked” prices utilizing evaluated prices obtained from third party pricing services or broker-dealers.

A description of the standard inputs that may generally be considered by the third party pricing vendors in determining their evaluated prices is provided below.

 

Security Type

  

Standard inputs generally considered by third-party pricing vendors

Corporate debt, government debt, municipal, mortgage-backed and asset-backed securities    Reported trade data, broker-dealer price quotations, benchmark yields, issuer spreads on comparable securities, the credit quality, yield, maturity, and other appropriate factors.
Loans    Information obtained from market participants regarding reported trade data and broker-dealer price quotations.
Event-linked bonds    Information obtained from market participants regarding reported trade data and broker-dealer price quotations.

If a market value or price cannot be determined for a security using the methodologies described above, or if, in the “good faith” opinion of the Manager, the market value or price obtained does not constitute a “readily available market quotation,” or a significant event has occurred that would materially affect the value of the security the security is fair valued either (i) by a standardized fair valuation methodology applicable to the security type or the significant event as previously approved by the Valuation Committee and the Fund’s Board or

 

5    OPPENHEIMER CAPITAL APPRECIATION FUND


NOTES TO STATEMENT OF INVESTMENTS Unaudited / (Continued)

Securities Valuation (Continued)

 

(ii) as determined in good faith by the Manager’s Valuation Committee. The Valuation Committee considers all relevant facts that are reasonably available, through either public information or information available to the Manager, when determining the fair value of a security. Fair value determinations by the Manager are subject to review, approval and ratification by the Fund’s Board at its next regularly scheduled meeting covering the calendar quarter in which the fair valuation was determined. Those fair valuation standardized methodologies include, but are not limited to, valuing securities at the last sale price or initially at cost and subsequently adjusting the value based on: changes in company specific fundamentals, changes in an appropriate securities index, or changes in the value of similar securities which may be further adjusted for any discounts related to security-specific resale restrictions. When possible, such methodologies use observable market inputs such as unadjusted quoted prices of similar securities, observable interest rates, currency rates and yield curves. The methodologies used for valuing securities are not necessarily an indication of the risks associated with investing in those securities nor can it be assured that the Fund can obtain the fair value assigned to a security if it were to sell the security.

To assess the continuing appropriateness of security valuations, the Manager, or its third party service provider who is subject to oversight by the Manager, regularly compares prior day prices, prices on comparable securities, and sale prices to the current day prices and challenges those prices exceeding certain tolerance levels with the third party pricing service or broker source. For those securities valued by fair valuations, whether through a standardized fair valuation methodology or a fair valuation determination, the Valuation Committee reviews and affirms the reasonableness of the valuations based on such methodologies and fair valuation determinations on a regular basis after considering all relevant information that is reasonably available.

Classifications

Each investment asset or liability of the Fund is assigned a level at measurement date based on the significance and source of the inputs to its valuation. Various data inputs are used in determining the value of each of the Fund’s investments as of the reporting period end. These data inputs are categorized in the following hierarchy under applicable financial accounting standards:

1) Level 1-unadjusted quoted prices in active markets for identical assets or liabilities (including securities actively traded on a securities exchange)

2) Level 2-inputs other than unadjusted quoted prices that are observable for the asset or liability (such as unadjusted quoted prices for similar assets and market corroborated inputs such as interest rates, prepayment speeds, credit risks, etc.)

3) Level 3-significant unobservable inputs (including the Manager’s own judgments about assumptions that market participants would use in pricing the asset or liability).

The inputs used for valuing securities are not necessarily an indication of the risks associated with investing in those securities.

 

6    OPPENHEIMER CAPITAL APPRECIATION FUND


NOTES TO STATEMENT OF INVESTMENTS Unaudited / (Continued)

Securities Valuation (Continued)

 

The table below categorizes amounts as of May 31, 2013 based on valuation input level:

 

     Level 1—
Unadjusted
Quoted Prices
     Level 2—
Other
Significant
Observable
Inputs
     Level 3—
Significant
Unobservable
Inputs
     Value  

Assets Table

  

Investments, at Value:

  

Common Stock

           

Consumer Discretionary

   $ 757,182,297       $ —        $ —        $ 757,182,297   

Consumer Staples

     424,083,303         143,834,356         —          567,917,659   

Energy

     336,392,487         —          —          336,392,487   

Financials

     218,506,774         —          —          218,506,774   

Health Care

     604,869,754         149,474,140         —          754,343,894   

Industrials

     650,395,302         —          —          650,395,302   

Information Technology

     1,200,419,452         —          —          1,200,419,452   

Materials

     264,932,152         —          —          264,932,152   

Investment Company

     93,508,518         —          —          93,508,518   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Assets

   $ 4,550,290,039       $ 293,308,496       $ —        $ 4,843,598,535   
  

 

 

    

 

 

    

 

 

    

 

 

 

Currency contracts and forwards, if any, are reported at their unrealized appreciation/ depreciation at measurement date, which represents the change in the contract’s value from trade date. Futures, if any, are reported at their variation margin at measurement date, which represents the amount due to/from the Fund at that date. All additional assets and liabilities included in the above table are reported at their market value at measurement date.

The table below shows the transfers between Level 1 and Level 2. The Fund’s policy is to recognize transfers in and transfers out as of the beginning of the reporting period.

 

     Transfers out of
Level 1*
    Transfers into
Level 2*
 

Assets Table

    

Investments, at Value:

    

Common Stocks

    

Consumer Staples

   $ (142,694,393   $ 142,694,393   

Health Care

     (145,341,178     145,341,178   
  

 

 

   

 

 

 

Total Assets

   $ (288,035,571   $ 288,035,571   
  

 

 

   

 

 

 

 

* Transferred from Level 1 to Level 2 because of the absence of a readily available unadjusted quoted market price due to a significant event occurring before the Fund’s assets were valued but after the close of the securities’ respective exchanges.

Currency contracts and forwards, if any, are reported at their unrealized appreciation/ depreciation at measurement date, which represents the change in the contract’s value from trade date. Futures, if any, are reported at their variation margin at measurement date, which represents the amount due to/from the Fund at that date. All additional assets and liabilities included in the above table are reported at their market value at measurement date.

Federal Taxes

The approximate aggregate cost of securities and other investments and the composition of unrealized appreciation and depreciation of securities and other investments for federal income tax purposes as of May 31, 2013 are noted below. The primary difference between book and tax appreciation or depreciation of securities and other investments, if applicable, is attributable to the tax deferral of losses.

 

Federal tax cost of securities

   $ 3,189,883,145   
  

 

 

 

Gross unrealized appreciation

   $ 1,679,261,092   

Gross unrealized depreciation

     (25,545,702
  

 

 

 

Net unrealized appreciation

   $ 1,653,715,390   
  

 

 

 

 

7    OPPENHEIMER CAPITAL APPRECIATION FUND


Item 2. Controls and Procedures.

 

  (a) Based on their evaluation of the registrant’s disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940 (17 CFR 270.30a-3(c)) as of 5/31/2013, the registrant’s principal executive officer and principal financial officer found the registrant’s disclosure controls and procedures to provide reasonable assurances that information required to be disclosed by the registrant in the reports that it files under the Securities Exchange Act of 1934 (a) is accumulated and communicated to the registrant’s management, including its principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure, and (b) is recorded, processed, summarized and reported, within the time periods specified in the rules and forms adopted by the U.S. Securities and Exchange Commission.

 

  (b) There have been no significant changes in the registrant’s internal controls over financial reporting that occurred during the registrant’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 3. Exhibits.

Exhibits attached hereto.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Oppenheimer Capital Appreciation Fund

 

By:

  /s/ William F. Glavin, Jr.
  William F. Glavin, Jr.
  Principal Executive Officer

Date:

  7/9/2013

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By:

  /s/ William F. Glavin, Jr.
  William F. Glavin, Jr.
  Principal Executive Officer

Date:

  7/9/2013

 

By:

  /s/ Brian W. Wixted
 

Brian W. Wixted

  Principal Financial OfficerPrincipal Financial Officer

Date:

  7/9/2013
EX-99.CERT 2 d549337dex99cert.htm SECTION 302 CERTIFICATIONS Section 302 Certifications

Exhibit 99.CERT

Section 302 Certifications

CERTIFICATIONS

I, William F. Glavin, Jr., certify that:

 

1. I have reviewed this report on Form N-Q of Oppenheimer Capital Appreciation Fund;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5. The registrant’s other certifying officer and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of Trustees (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/ William F. Glavin, Jr.

William F. Glavin, Jr.
Principal Executive Officer
Date: 7/9/2013


Exhibit 99.CERT

Section 302 Certifications

CERTIFICATIONS

I, Brian W. Wixted, certify that:

 

1. I have reviewed this report on Form N-Q of Oppenheimer Capital Appreciation Fund;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5. The registrant’s other certifying officer and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of Trustees (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/ Brian W. Wixted

Brian W. Wixted
Principal Financial Officer
Date: 7/9/2013